Cycle Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees
Cycle Pharmaceuticals is a Cambridge-based pharmaceutical manufacturer focused on developing and delivering therapies for patients with neurological, rare metabolic, and rare immunological conditions, many of which have a genetic basis, and it also provides a treatment option for certain rare leukemias. The company maintains a presence in the United States, including an office in Detroit, while its headquarters remain in Cambridge. Its portfolio includes HARLIKU tablets for alkaptonuria and PHYRAGO, its first oncology product launched in the United States, as well as Cycle Vita PKU, an AI-powered app introduced to support PKU management. In early 2026, the company expanded its geographic reach and patient-access initiatives by extending its Free Goods Programme to Morocco and Egypt. It completed the acquisition of Applied Therapeutics, signaling a broadened clinical-stage footprint. The organization emphasizes patient-centered care by providing treatments and services across its neurological, rare metabolic and rare immunological conditions, and related hematologic indications.
1-888-653-2347 
support@leadiq.com 
